Rankings
▼
Calendar
HRMY Q1 2019 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$63M
Net Income
-$63M
EPS (Diluted)
$-1.29
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$61M
Stock-Based Comp.
$326,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$82M
Cash & Equivalents
-$84M
← FY 2019
All Quarters
Q2 2019 →
